Skip to Content

Notice

Minimizing Medication Errors-Methods for Evaluating Proprietary Names for Their Confusion Potential; Public Meeting; Correction

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration; HHS.

ACTION:

Notice of public meeting; correction.

SUMMARY:

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 30, 2003 (68 FR 32529). The document announced a public meeting to explore current methods being used to evaluate proprietary drug names to reduce medication errors due to similarity in drug names. The document was published with the incorrect docket number. This document corrects that error.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Joyce A. Strong, Chief, Regulations Editorial Section (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In FR Doc. 03-13591, appearing on page 35679 in the Federal Register of May 30, 2003, the following correction is made:

1. On page 32529, in the third column, the Docket No. “02N-0201” should be corrected to read “2003N-0201”.

Start Signature

Dated: June 25, 2003.

Jeffrey Shuren,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 03-16617 Filed 7-1-03; 8:45 am]

BILLING CODE 4160-01-S